Volume 83, Issue 1 pp. 57-66
Original Article

Clinicopathologic and genetic characterization of angiofibroma of soft tissue: a study of 12 cases including two cases with AHRR::NCOA3 gene fusion

Kyoko Yamashita

Corresponding Author

Kyoko Yamashita

Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

Address for correspondence: K Yamashita, Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 135-8550, Japan. e-mail: [email protected]Search for more papers by this author
Satoko Baba

Satoko Baba

Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

Search for more papers by this author
Yuki Togashi

Yuki Togashi

Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

Search for more papers by this author
Akito Dobashi

Akito Dobashi

Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

Search for more papers by this author
Keisuke Ae

Keisuke Ae

Department of Orthopedic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

Search for more papers by this author
Seiichi Matsumoto

Seiichi Matsumoto

Department of Orthopedic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

Search for more papers by this author
Miwa Tanaka

Miwa Tanaka

Project for Cancer Epigenomics, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

Search for more papers by this author
Takuro Nakamura

Takuro Nakamura

Department of Experimental Pathology, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan

Search for more papers by this author
Kengo Takeuchi

Kengo Takeuchi

Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

Search for more papers by this author
First published: 01 March 2023
Citations: 5

Abstract

Aims

Angiofibroma of soft tissue (AFST) is a benign tumour characterised by prominent arborizing blood vessels throughout the lesion. Approximately two-thirds of AFST cases were reported to have AHRR::NCOA2 fusion, and only two cases have been reported to have other gene fusions: GTF2I::NCOA2 or GAB1::ABL1. Although AFST is included in fibroblastic and myofibroblastic tumours in the World Health Organization's 2020 classification, histiocytic markers, especially CD163, have been reported to be positive in almost all examined cases, and it still remains the possibility of a fibrohistiocytic nature of the tumour. Therefore, we aimed to clarify the genetic and pathological spectrum of AFST and identify whether histiocytic marker-positive cells were true neoplastic cells.

Methods and results

We evaluated 12 AFST cases, which included 10 cases with AHRR::NCOA2 and two with AHRR::NCOA3 fusions. Pathologically, nuclear palisading, which has not been reported in AFST, was detected in two cases. Furthermore, one tumour resected by additional wide resection revealed severe infiltrative growth. Immunohistochemical analysis indicated varying levels of desmin-positive cells in nine cases, whereas CD163- and CD68-positive cells were diffusely distributed in all 12 cases. We also performed double immunofluorescence staining and immunofluorescence in situ hybridisation in four resected cases with >10% desmin-positive tumour cells. The results suggested that the CD163-positive cells differed from desmin-positive cells with AHRR::NCOA2 fusion in all four cases.

Conclusion

Our findings suggested that AHRR::NCOA3 could be the second most frequent fusion gene, and histiocytic marker-positive cells are not genuine neoplastic cells in AFST.

Graphical Abstract

Two cases with AHRR::NCOA3 fusion were included in 12 cases of angiofibroma of soft tissue (AFST). Diffusely distributed CD163-positive cells were different from true neoplastic cells that were positive for desmin to varying degrees.

Conflict of Interest

The authors declare no conflicts of interest.

Data availability statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.